SS-31 (Elamipretide) is a mitochondria-targeted peptide studied for cardiolipin stabilization, ATP production, and protection against mitochondrial dysfunction. Physician-reviewed. Prescription required.
SS-31 (elamipretide) is a mitochondria-targeted peptide designed to improve mitochondrial function, bioenergetics, and reduce oxidative stress. It physically associates with mitochondrial membranes and preserves electron transport chain (ETC) integrity.
SS-31 has been studied for its ability to maintain mitochondrial membrane integrity, enhance ATP production, reduce reactive oxygen species (ROS), and protect against mitochondrial permeability transition pore (mPTP) opening. It represents one of the most mechanistically targeted longevity compounds currently under investigation. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| Targeted mitochondrial localization | Selective accumulation in mitochondria |
| Cardiolipin stabilization | Maintains IMM structure and ETC integrity |
| Enhanced oxidative phosphorylation | Improved ATP production |
| Reduced ROS generation | Lower oxidative stress |
| Prevention of mPTP opening | Protection against cell death |
| Anti-inflammatory signaling | Reduced chronic inflammation |
| Neuroprotection | Neuronal survival and reduced degeneration |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with SS-31 / Elamipretide protocol candidates in clinical practice:
Mitochondrial Optimization
Individuals with mitochondrial decline or dysfunction seeking physician-supervised SS-31 support.
Cardiovascular Longevity
Individuals with cardiovascular health goals where mitochondrial membrane integrity may be clinically relevant.
Neurological Support
Individuals seeking physician-reviewed neuroprotective support through mitochondrial mechanisms.
Advanced Longevity Protocol
Individuals with established longevity protocols adding physician-reviewed mitochondrial targeting.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
0.5–4 mg/day
Administration
Subcutaneous injection
Duration
Physician-determined cycles
Frequency
Daily to 3x weekly (physician-determined)
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.
Begin your SS-31 / Elamipretide protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
SS-31 (Elamipretide) is a mitochondria-targeting peptide that protects and restores mitochondrial function. It is used for age-related mitochondrial decline, cardiovascular health, and cellular energy optimization.
SS-31 is studied for age-related mitochondrial dysfunction, heart failure, kidney disease, neurodegeneration, and muscle atrophy. It is used in longevity protocols to maintain cellular energy production.
SS-31 is a subcutaneous injectable at Verum Health. Due to its targeted mechanism, dosing and protocol length are carefully determined by your physician.
Yes. SS-31 + NAD+ is a potent mitochondrial support stack — SS-31 protects mitochondrial membranes while NAD+ supports the energy production enzymes within them.